Diplomat Pharmacy (DPLO) Tops Q4 EPS by 2c, Slight Miss on Revenues; Offers FY18 EPS Below Consensus, FY18 Revenue Mid-Point Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Diplomat Pharmacy (DPLO) Tops Q4 EPS by 2c, Slight Miss on Revenues; Offers FY18 EPS Below Consensus, FY18 Revenue Mid-Point Outlook Below Consensus

Diplomat Pharmacy (DPLO) PT Lowered to $22 at Baird

February 27, 2018 8:26 AM EST

Baird lowered its price target on Diplomat Pharmacy (NYSE: DPLO) to $22.00 (from $24.00) while maintaining a Neutral rating.

... More

Diplomat Pharmacy (DPLO) PT Raised to $25 at Cowen

February 27, 2018 7:12 AM EST

Cowen raised its price target on Diplomat Pharmacy (NYSE: DPLO) to $25.00 (from $20.00) while maintaining a Market Perform rating.

Analyst Charles Rhyee commented, "DPLO reported 4Q adj. EBITDA ahead of consensus due to better than expected gross margins due to improved drug purchasing,... More

Diplomat Pharmacy (DPLO) PT Raised to $28 at Needham & Company

February 27, 2018 7:08 AM EST

Needham & Company raised its price target on Diplomat Pharmacy (NYSE: DPLO) to $28.00 (from $26.00) while maintaining a Buy rating.

Analyst Kevin Caliendo commented, "It was a largely uneventful 4Q earnings report for DPLO last night, with a small beat in the quarter and a small... More